RecallHawk

Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 Analyzer

Abbott Diagnostics Technologies AS

Summary

Abbott Diagnostics Technologies AS received 510(k) clearance for Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 Analyzer, a LCP device. Cleared on 2023-09-27.

Details

Source

510(k) Clearance

External ID

K214117

Action Date

2023-09-27

Status

Dual Track

Category

device

Product Code

LCP

Product Description

Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 Analyzer. Product code: LCP.

Context & Analysis

A 510(k) clearance means the FDA determined this device is substantially equivalent to a legally marketed device. This is one of 403 device clearances issued this month.

Abbott Diagnostics Technologies AS has 2 FDA actions in our database, including 1 recall and 1 clearance.

Frequently Asked Questions

What does 510(k) clearance mean?

A 510(k) is an FDA premarket submission demonstrating that a device is substantially equivalent to a legally marketed device. It does NOT mean FDA approval — it means the device is cleared for marketing because it's similar enough to an existing cleared device. Most medical devices reach market via 510(k) rather than full PMA approval.

How often does Abbott Diagnostics Technologies AS have FDA actions?

Abbott Diagnostics Technologies AS has 2 FDA actions in our database, including 1 recall and 1 device clearance.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "K214117" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions